Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery
Conditions
Interventions
- DRUG: sorafenib tosylate, HACE : Doxorubicin Hydrochloride and Mitomycin C
- OTHER: laboratory biomarker analysis
Sponsor
Rutgers, The State University of New Jersey